Today’s Price Action: Exponent, Inc. Stock Price Hits All-Time High Today

Today's Price Action: Exponent, Inc. Stock Price Hits All Time High Today

The stock of Exponent, Inc. (NASDAQ:EXPO) reached all time high today, Nov, 24 and still has $66.20 target or 6.00% above today’s $62.45 share price. This indicates more upside for the $1.63 billion company. This technical setup was reported by Barchart.com. If the $66.20 PT is reached, the company will be worth $97.80M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. The stock decreased 0.08% or $0.05 on November 23, hitting $62.45. About 81,328 shares traded hands. Exponent, Inc. (NASDAQ:EXPO) has risen 23.37% since April 22, 2016 and is uptrending. It has outperformed by 17.96% the S&P500.

Analysts await Exponent, Inc. (NASDAQ:EXPO) to report earnings on February, 1. They expect $0.34 earnings per share, down 5.56% or $0.02 from last year’s $0.36 per share. EXPO’s profit will be $8.87M for 45.92 P/E if the $0.34 EPS becomes a reality. After $0.42 actual earnings per share reported by Exponent, Inc. for the previous quarter, Wall Street now forecasts -19.05% negative EPS growth.

According to Zacks Investment Research, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.”

Insitutional Activity: The institutional sentiment decreased to 1.06 in Q2 2016. Its down 0.65, from 1.71 in 2016Q1. The ratio turned negative, as 12 funds sold all Exponent, Inc. shares owned while 39 reduced positions. 19 funds bought stakes while 68 increased positions. They now own 23.37 million shares or 1.97% more from 22.92 million shares in 2016Q1.
Roffman Miller Inc Pa accumulated 1.27% or 132,122 shares. The New York-based Metropolitan Life Communications Ny has invested 0.01% in Exponent, Inc. (NASDAQ:EXPO). Huntington Commercial Bank reported 4,430 shares or 0.01% of all its holdings. Jpmorgan Chase holds 0% or 289,869 shares in its portfolio. The Louisiana-based Louisiana State Employees Retirement System has invested 0.04% in Exponent, Inc. (NASDAQ:EXPO). Hussman Strategic last reported 50,000 shares in the company. The Massachusetts-based Rhumbline Advisers has invested 0.01% in Exponent, Inc. (NASDAQ:EXPO). Confluence Mgmt has 33,594 shares for 0.05% of their US portfolio. Prudential holds 78,274 shares or 0.01% of its portfolio. California State Teachers Retirement reported 53,642 shares or 0.01% of all its holdings. Blackrock Fund Advsr, a California-based fund reported 1.63M shares. Gemmer Asset Ltd, a California-based fund reported 92 shares. Ftb Advsr has invested 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Moreover, Henderson Group Inc Public Limited has 0.17% invested in Exponent, Inc. (NASDAQ:EXPO) for 350,913 shares. Legal & General Group Inc Pcl holds 0% or 5,658 shares in its portfolio.

Insider Transactions: Since May 27, 2016, the stock had 0 insider purchases, and 14 sales for $3.97 million net activity. SCHLENKER RICHARD L JR also sold $829,491 worth of Exponent, Inc. (NASDAQ:EXPO) on Tuesday, October 25. JOHNSTON PAUL R had sold 5,500 shares worth $325,993 on Thursday, July 14. On Tuesday, October 25 the insider RIGGINS STEPHEN C sold $135,882. On Friday, August 12 the insider CALIGIURI ROBERT D sold $67,172. Boehm Paul sold $260,910 worth of stock or 5,000 shares. Kytomaa Harri also sold $340,480 worth of Exponent, Inc. (NASDAQ:EXPO) on Monday, November 14. 4,000 shares were sold by GAULKE MICHAEL R, worth $238,198.

Another recent and important Exponent, Inc. (NASDAQ:EXPO) news was published by Streetinsider.com which published an article titled: “Exponent, Inc. (EXPO) Reports In-Line Q2 EPS; Trims Outlook” on July 19, 2016.

EXPO Company Profile

Exponent, Inc. (Exponent), incorporated on May 9, 1989, along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. The Company’s service offerings are provided on a project-by-project basis. It operates over 20 practices and centers in two operating divisions: Engineering and Other Scientific, and Environmental and Health. The Company’s Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences and vehicle analysis services. The Company’s Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology. Exponent serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing and technology, among others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment